SLDB (STOCKS)
Solid Biosciences Inc. Common Stock
$9.080000
+0.015000 (+0.17%)
Prev close: $9.065000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Alexander Gery Cumbo
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,100.47M
- Employees
- 100
- P/E (TTM)
- -4.75
- P/B (TTM)
- 2.55
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.38 | $-0.48 | +0.0976 | +20.44% |
|
Mar 2026 (Q1)
|
$-0.52 | $-0.44 | -0.0778 | -17.59% |
|
Dec 2025 (Q4)
|
$-0.53 | $-0.53 | -0.0008 | -0.15% |
|
Sep 2025 (Q3)
|
$-0.48 | $-0.45 | -0.0325 | -7.26% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $5.05M |
| Operating Expenses | $212.15M |
| Depreciation and Amortization | $1.63M |
| Research and Development | $167.40M |
| Other Operating Expenses | $43.50M |
| Operating Income/Loss | -$212.15M |
| Income/Loss From Continuing Operations After Tax | -$206.97M |
| Income/Loss From Continuing Operations Before Tax | -$206.97M |
| Net Income/Loss | -$207.10M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$207.10M |
| Net Income/Loss Available To Common Stockholders, Basic | -$207.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.91 |
| Diluted Earnings Per Share | -$1.91 |
| Basic Average Shares | 350,353,251 |
| Diluted Average Shares | 350,353,251 |
| Assets | $420.58M |
| Current Assets | $395.11M |
| Cash | $377.70M |
| Other Current Assets | $17.41M |
| Noncurrent Assets | $25.47M |
| Fixed Assets | $3.96M |
| Other Non-current Assets | $21.51M |
| Liabilities | $46.51M |
| Current Liabilities | $28.58M |
| Accounts Payable | $4.36M |
| Other Current Liabilities | $24.22M |
| Noncurrent Liabilities | $17.92M |
| Equity | $374.08M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $374.08M |
| Liabilities And Equity | $420.58M |
| Net Cash Flow From Operating Activities | -$186.84M |
| Net Cash Flow From Operating Activities, Continuing | -$186.84M |
| Net Cash Flow From Investing Activities | -$87.09M |
| Net Cash Flow From Investing Activities, Continuing | -$87.09M |
| Net Cash Flow From Financing Activities | $293.82M |
| Net Cash Flow From Financing Activities, Continuing | $293.82M |
| Net Cash Flow | $19.88M |
| Net Cash Flow, Continuing | $19.88M |
| Comprehensive Income/Loss | -$207.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$207.11M |
| Other Comprehensive Income/Loss | -$10.00K |